This compound is an Fmoc-protected amino acid derivative featuring a phthalimide-protected lysine side chain. It is primarily used as a building block in solid-phase peptide synthesis, enabling the selective incorporation of modified lysine residues.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 83999-93-3
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(6-methoxypyridin-3-yl)propanoic acid
pharmaceutical intermediate
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-methoxy-2-methylphenyl)propanoic acid
pharmaceutical intermediate
(2S)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-methyl-9-decenoic acid
pharmaceutical intermediate
Fmoc-beta-Alanine
pharmaceutical intermediate
2,3-dichloro-5,6-dicyanobenzoquinone
pharmaceutical intermediate
Fmoc-N-Methyl-L-alanine
pharmaceutical intermediate
Fmoc-N-methyl-L-valine
pharmaceutical intermediate
Chitosan, 2-hydroxypropyl ether
pharmaceutical intermediate
(2S)-6-(1,3-dioxoisoindol-2-yl)-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoic acid
MDYADJADRHFGPE-VWLOTQADSA-N
C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)N[C@@H](CCCCN4C(=O)C5=CC=CC=C5C4=O)C(=O)O